前列腺癌:新的遗传和免疫生物标志物
Mohammad Samare-Najaf1, Hosein Kouchaki2, Seyed Moein Mahini3
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Clinica chimica acta; international journal of clinical chemistry
|February 5, 2024
概括
由于高死亡率,早期发现前列腺癌 (PCa) 是至关重要的. 本综述探讨了用于准确PCa诊断,分期和预后的非侵入性生物标志物面板,并解决了当前方法的局限性.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
背景情况:
- 前列腺癌 (PCa) 是男性的主要恶性瘤,全球发病率不断增加.
- 目前的诊断方法,如血清测试缺乏特异性和敏感性;组织学是侵入性的,不适合监测.
- 对于早期PCa诊断,分期和预后而言,非常需要非侵入性方法.
研究的目的:
- 审查目前的前列腺癌的非侵入性诊断,分期和预后策略.
- 检查各种生物标志物小组在改善PCa管理方面的潜力.
- 确定PCa生物标志物研究中的有希望的未来方向.
主要方法:
- 对非侵入性PCa诊断和预后方法的研究进行系统审查.
- 生物标志物的分类为遗传,免疫和异质子组.
- 对PCa检测,分期和预后的生物标志物面板的分析.
主要成果:
- 目前的非侵入性策略包括遗传 (基因标记物,非编码RNA),免疫 (细胞因子,抗体) 和异质 (PSA相关,尿路生物标记物) 方法.
- 生物标志物面板在提高PCa诊断,分期和预后的准确性方面表现有前途.
- 这些面板的进一步验证和整合对于临床应用至关重要.
结论:
- 非侵入性生物标记面板代表了前列腺癌诊断和管理的重大进步.
- 未来的研究应该专注于验证和结合不同的生物标志物,以提高临床效用.
- 有效的生物标志物策略是克服当前PCa检测方法的局限性的关键.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.